COX6B2 and pancreatic adenocarcinoma: Furthermore, although COX6B2 has been reported to drive PAAD progression by enhancing mitochondrial OXPHOS,[15a] its potential oncogenic functions in extra‐mitochondrial compartments (e.g., cytosol) parallel to COA4 await mechanistic exploration.